Serotonin transporter protein (SERT) plays a crucial role in synaptic clearance of 5-hydroxytryptophan (5-HTP) and serves as a potential target for SSRI-based anti-MDD therapies to inhibit the entry of 5-HTP. This evidence concerns the gene SLC6A4 and major depressive disorder.